| 2026 |
| 10/06 | 36 | 36 | 35 | 36 | 0% | 459,600 | - | -2.7% |
| 10/06 | （IR情報）8:45 共同開発品Tie2受容体アゴニスト(AV-001)の皮下注製剤の開発推進に向けた助成金獲得のお知らせ |
| 10/05 | 35 | 36 | 35 | 36 | +2.86% | 1,551,200 | - | -2.7% |
| 10/02 | 36 | 37 | 35 | 35 | -2.78% | 3,991,400 | - | -5.41% |
| 10/01 | （IR情報）16:00 行使価額修正条項付新株予約権の月間行使状況に関するお知らせ |
| 10/01 | 37 | 38 | 36 | 36 | -5.26% | 960,900 | - | -5.26% |
| 09/30 | 36 | 38 | 36 | 38 | +5.56% | 2,698,200 | - | 0% |
| 09/30 | （空売り報告）Nomura International plc 1,309,942株（0.32%）-0.2%義務消失 |
| 09/30 | （空売り報告）モルガン・スタンレーMUFG証券 1,983,329株（0.49%）-0.09%義務消失 |
| 09/30 | （空売り報告）MERRILL LYNCH INTERNATIONAL 2,752,840株（0.69%）+0.01% |
| 09/30 | （空売り報告）Barclays Capital Securities Ltd 3,974,609株（0.99%）-0.1% |
| 09/29 | （5%ルール）グロースパートナーズ（15.39%）古川徳厚（15.39%） |
| 09/29 | 36 | 36 | 35 | 36 | 0% | 698,300 | - | -5.26% |
| 09/29 | （IR情報）8:45 共同開発品Tie2受容体アゴニスト(AV-001)の前期第2相臨床試験登録完了のお知らせ |
| 09/28 | （IR情報）16:00 グロースパートナーズとの事業提携による企業価値向上への取り組みについて |
| 09/28 | 37 | 37 | 35 | 36 | 0% | 1,406,500 | - | -5.26% |
| 09/28 | （空売り報告）Nomura International plc 2,095,300株（0.52%）再IN |
| 09/25 | 36 | 37 | 36 | 36 | 0% | 835,900 | - | -5.26% |
| 09/24 | （5%ルール）Cantor Fitzgerald Europe（0%） |
| 09/24 | 36 | 37 | 35 | 36 | 0% | 1,518,300 | - | -7.69% |
| 09/18 | 35 | 36 | 35 | 36 | +2.86% | 857,300 | - | -7.69% |
| 09/17 | 35 | 36 | 35 | 35 | 0% | 239,200 | - | -10.26% |
| 09/17 | （空売り報告）Barclays Capital Securities Ltd 4,359,509株（1.09%）-0.01% |
| 09/16 | 35 | 36 | 35 | 35 | -2.78% | 1,038,300 | - | -12.5% |
| 09/16 | （空売り報告）Nomura International plc 1,982,416株（0.49%）再IN |
| 09/16 | （空売り報告）モルガン・スタンレーMUFG証券 2,333,229株（0.58%）-0.02% |
| 09/16 | （空売り報告）Barclays Capital Securities Ltd 4,399,909株（1.1%）+0.05% |
| 09/15 | （IR情報）16:00 第46回新株予約権(行使価額修正条項付)の取得及び消却の完了に関するお知らせ |
| 09/15 | 36 | 36 | 34 | 36 | 0% | 4,033,900 | - | -12.2% |
| 09/15 | （空売り報告）MERRILL LYNCH INTERNATIONAL 2,734,040株（0.68%）-0.01% |
| 09/14 | 36 | 37 | 36 | 36 | 0% | 753,700 | - | -12.2% |
| 09/11 | 38 | 38 | 36 | 36 | -7.69% | 4,711,500 | - | -14.29% |
| 09/10 | 37 | 39 | 37 | 39 | +2.63% | 1,110,800 | - | -7.14% |
| 09/10 | （空売り報告）MERRILL LYNCH INTERNATIONAL 2,762,740株（0.69%）+0.02% |
| 09/09 | 38 | 38 | 37 | 38 | 0% | 2,034,000 | - | -11.63% |
| 09/09 | （空売り報告）Barclays Capital Securities Ltd 4,213,709株（1.05%）-0.06% |
| 09/08 | 39 | 40 | 38 | 38 | -2.56% | 3,049,600 | - | -11.63% |
| 09/07 | 40 | 40 | 39 | 39 | 0% | 420,800 | - | -9.3% |
| 09/04 | （5%ルール）グロースパートナーズ（15.72%）古川徳厚（15.72%） |
| 09/04 | 39 | 40 | 39 | 39 | 0% | 384,900 | - | -11.36% |
| 09/03 | 39 | 40 | 39 | 39 | 0% | 488,700 | - | -11.36% |
| 09/02 | 40 | 40 | 39 | 39 | -2.5% | 574,400 | - | -11.36% |
| 09/01 | （IR情報）16:00 第2回無担保社債(私募債)の償還完了に関するお知らせ |
| 09/01 | （IR情報）16:00 行使価額修正条項付新株予約権の月間行使状況に関するお知らせ |
| 09/01 | 40 | 40 | 39 | 40 | +2.56% | 549,900 | - | -11.11% |
| 08/31 | （IR情報）12:00 第三者割当第47回新株予約権(行使価額修正条項付)、第48回新株予約権及び第2回無担保転換社債型新株予約権付社債の払込完了に関するお知らせ |
| 08/31 | 41 | 41 | 39 | 39 | -2.5% | 744,000 | - | -13.33% |
| 08/31 | （空売り報告）モルガン・スタンレーMUFG証券 2,397,429株（0.6%）+0.08% |
| 08/31 | （空売り報告）Barclays Capital Securities Ltd 4,464,409株（1.11%）+0.03% |
| 08/28 | 39 | 41 | 38 | 40 | +2.56% | 2,521,800 | - | -11.11% |
| 08/28 | （空売り報告）MERRILL LYNCH INTERNATIONAL 2,683,840株（0.67%）+0.03% |
| 08/28 | （空売り報告）Barclays Capital Securities Ltd 4,323,609株（1.08%）-0.04% |
| 08/27 | 40 | 40 | 38 | 39 | 0% | 989,900 | - | -15.22% |
| 08/27 | （空売り報告）Barclays Capital Securities Ltd 4,474,909株（1.12%）+0.03% |
| 08/26 | 39 | 40 | 38 | 39 | 0% | 846,400 | - | -15.22% |
| 08/26 | （空売り報告）Barclays Capital Securities Ltd 4,379,009株（1.09%）-0.07% |
| 08/25 | （IR情報）16:00 (訂正)新株予約権(46)の取得消却、第2回社債の償還と新株予約権(47行使価額修正、48)、第2回新株予約権付社債の発行、GP社との事業提携契約 |
| 08/25 | 39 | 40 | 37 | 39 | 0% | 4,567,800 | - | -15.22% |
| 08/25 | （空売り報告）MERRILL LYNCH INTERNATIONAL 2,564,940株（0.64%）+0.04% |
| 08/24 | 39 | 40 | 39 | 39 | 0% | 1,648,600 | - | -17.02% |
| 08/21 | 43 | 43 | 37 | 39 | -7.14% | 10,004,300 | - | -17.02% |
| 08/21 | （空売り報告）MERRILL LYNCH INTERNATIONAL 2,406,940株（0.6%）+0.01% |
| 08/20 | 43 | 43 | 42 | 42 | 0% | 1,076,400 | - | -12.5% |
| 08/20 | （空売り報告）MERRILL LYNCH INTERNATIONAL 2,361,540株（0.59%）+0.01% |
| 08/19 | 45 | 45 | 42 | 42 | -6.67% | 6,034,300 | - | -12.5% |
| 08/19 | （空売り報告）モルガン・スタンレーMUFG証券 2,092,529株（0.52%）再IN |
| 08/19 | （空売り報告）Barclays Capital Securities Ltd 4,652,444株（1.16%）+0.18% |
| 08/18 | 46 | 46 | 45 | 45 | 0% | 913,400 | - | -6.25% |
| 08/18 | （空売り報告）MERRILL LYNCH INTERNATIONAL 2,345,740株（0.58%）+0.01% |
| 08/17 | 46 | 47 | 44 | 45 | -10% | 4,835,600 | - | -6.25% |
| 08/17 | （空売り報告）Barclays Capital Securities Ltd 3,913,752株（0.98%）+0.13% |
| 08/14 | （IR情報）17:16 営業外収益、営業外費用、特別利益、特別損失及び法人税等調整額の計上に関するお知らせ |
| 08/14 | （IR情報）17:15 2026年12月期第2四半期(中間期)決算短信〔日本基準〕(連結) |
| 08/14 | （IR情報）17:15 新株予約権(46)の取得消却、第2回社債の償還と第三者割当新株予約権(47行使価額修正、48)、第2回新株予約権付社債の発行、GP社との事業提携契約 |
| 08/14 | 50 | 51 | 49 | 50 | 0% | 580,600 | - | +2.04% |
| 08/13 | 51 | 51 | 49 | 50 | -1.96% | 1,479,400 | - | +2.04% |
| 08/12 | 50 | 51 | 49 | 51 | +4.08% | 971,800 | - | +4.08% |
| 08/10 | 48 | 50 | 48 | 49 | +2.08% | 779,500 | - | 0% |
| 08/07 | 48 | 49 | 48 | 48 | -2.04% | 170,600 | - | -2.04% |
| 08/06 | 49 | 50 | 48 | 49 | 0% | 921,500 | - | 0% |
| 08/05 | 48 | 50 | 47 | 49 | +4.26% | 1,481,000 | - | +2.08% |
| 08/05 | （空売り報告）Barclays Capital Securities Ltd 3,394,852株（0.85%）-0.05% |
| 08/04 | 47 | 48 | 47 | 47 | 0% | 455,200 | - | -2.08% |
| 08/03 | （IR情報）17:30 行使価額修正条項付新株予約権の月間行使状況に関するお知らせ |
| 08/03 | 47 | 48 | 46 | 47 | 0% | 651,500 | - | -2.08% |
| 07/31 | 47 | 48 | 47 | 47 | 0% | 347,300 | - | -2.08% |
| 07/31 | （空売り報告）MERRILL LYNCH INTERNATIONAL 2,275,640株（0.57%）+0.01% |
| 07/30 | 47 | 48 | 46 | 47 | 0% | 871,000 | - | -2.08% |
| 07/29 | 47 | 48 | 46 | 47 | 0% | 1,225,400 | - | -2.08% |
| 07/28 | （IR情報）16:00 当社提携先のVasomuneが2026年NATO NSPA CBRN会議においてTie2受容体アゴニスト(AV-001)の治療能力について発表 |
| 07/28 | 47 | 48 | 47 | 47 | 0% | 1,289,500 | - | -2.08% |
| 07/27 | 47 | 48 | 47 | 47 | 0% | 237,700 | - | -2.08% |
| 07/27 | （空売り報告）MERRILL LYNCH INTERNATIONAL 2,242,140株（0.56%）+0.01% |
| 07/24 | 48 | 48 | 47 | 47 | -2.08% | 243,500 | - | -2.08% |
| 07/23 | 48 | 48 | 47 | 48 | 0% | 479,400 | - | 0% |
| 07/23 | （空売り報告）Barclays Capital Securities Ltd 3,596,652株（0.9%）+0.1% |
| 07/22 | （IR情報）12:00 当社提携先のVasomuneが戦闘関連傷害における血管漏出について2026年軍医療システム研究シンポジウム(MHSRS)で発表 |
| 07/22 | 48 | 49 | 47 | 48 | 0% | 2,019,100 | - | 0% |
| 07/21 | 49 | 51 | 48 | 48 | 0% | 2,145,500 | - | 0% |
| 07/17 | 50 | 56 | 48 | 48 | -4% | 9,162,900 | - | 0% |
| 07/17 | （IR情報）8:45 HGF遺伝子治療用製品のPre-BLA Meeting及びBLA申請に関するお知らせ |
| 07/16 | 51 | 51 | 49 | 50 | 0% | 1,281,500 | - | +4.17% |
| 07/15 | 51 | 51 | 50 | 50 | 0% | 551,000 | - | +4.17% |
| 07/14 | （IR情報）16:00 社外取締役の辞任に関するお知らせ |
| 07/14 | 50 | 52 | 50 | 50 | -1.96% | 856,000 | - | +4.17% |
| 07/13 | 52 | 52 | 50 | 51 | 0% | 590,700 | - | +8.51% |
| 07/10 | 50 | 52 | 50 | 51 | 0% | 1,509,500 | - | +8.51% |
| 07/09 | 50 | 51 | 50 | 51 | +2% | 209,700 | - | +8.51% |
| 07/08 | 53 | 53 | 49 | 50 | -3.85% | 1,565,700 | - | +6.38% |
| 07/08 | （空売り報告）MERRILL LYNCH INTERNATIONAL 2,202,740株（0.55%）+0.01% |
| 07/08 | （空売り報告）Barclays Capital Securities Ltd 3,214,152株（0.8%）+0.04% |
| 07/07 | 50 | 53 | 49 | 52 | +6.12% | 2,315,800 | - | +10.64% |
| 07/06 | 47 | 50 | 47 | 49 | +4.26% | 1,304,200 | - | +4.26% |
| 07/06 | （空売り報告）Barclays Capital Securities Ltd 3,070,919株（0.76%）-0.09% |
| 07/03 | 47 | 48 | 46 | 47 | 0% | 979,900 | - | 0% |
| 07/02 | 47 | 48 | 47 | 47 | 0% | 420,300 | - | 0% |
| 07/01 | （IR情報）16:00 行使価額修正条項付新株予約権の月間行使状況に関するお知らせ |
| 07/01 | （IR情報）16:00 Asia Pacific Cell & Gene Therapy Excellence Awards 2026における受賞のお知らせ |
| 07/01 | 47 | 48 | 46 | 47 | 0% | 617,900 | - | 0% |
| 06/30 | 46 | 47 | 46 | 47 | 0% | 253,400 | - | 0% |
| 06/29 | 46 | 47 | 45 | 47 | +4.44% | 499,400 | - | 0% |
| 06/26 | （IR情報）16:00 つながる遺伝子ラボ Gene+Connect終了のお知らせ |
| 06/26 | 46 | 47 | 45 | 45 | -2.17% | 578,800 | - | -4.26% |
| 06/25 | 47 | 48 | 46 | 46 | -2.13% | 416,700 | - | -2.13% |
| 06/24 | 47 | 49 | 46 | 47 | 0% | 1,149,800 | - | 0% |
| 06/23 | 48 | 49 | 47 | 47 | -2.08% | 1,148,200 | - | 0% |
| 06/23 | （空売り報告）MERRILL LYNCH INTERNATIONAL 2,164,340株（0.54%）再IN |
| 06/22 | 48 | 49 | 47 | 48 | 0% | 848,000 | - | 0% |
| 06/22 | （空売り報告）Barclays Capital Securities Ltd 3,407,719株（0.85%）-0.07% |
| 06/19 | 47 | 48 | 46 | 48 | +2.13% | 834,500 | - | 0% |
| 06/18 | 47 | 48 | 46 | 47 | 0% | 1,074,400 | - | -2.08% |
| 06/18 | （空売り報告）Barclays Capital Securities Ltd 3,680,519株（0.92%）+0.03% |
| 06/17 | 44 | 49 | 44 | 47 | +6.82% | 2,809,800 | - | -2.08% |
| 06/16 | 45 | 46 | 44 | 44 | -2.22% | 1,715,800 | - | -8.33% |
| 06/16 | （空売り報告）Barclays Capital Securities Ltd 3,584,919株（0.89%）+0.17% |
| 06/15 | 45 | 46 | 45 | 45 | 0% | 598,500 | - | -6.25% |
| 06/12 | 45 | 46 | 45 | 45 | -2.17% | 860,400 | - | -8.16% |
| 06/11 | 45 | 46 | 45 | 46 | 0% | 1,063,500 | - | -6.12% |
| 06/10 | 46 | 47 | 45 | 46 | 0% | 1,228,900 | - | -6.12% |
| 06/09 | 46 | 47 | 46 | 46 | 0% | 780,600 | - | -8% |
| 06/08 | 47 | 47 | 46 | 46 | -2.13% | 1,878,900 | - | -8% |
| 06/08 | （空売り報告）Barclays Capital Securities Ltd 2,910,852株（0.72%）+0.06% |
| 06/05 | 47 | 48 | 47 | 47 | 0% | 528,200 | - | -6% |
| 06/04 | 48 | 48 | 47 | 47 | -2.08% | 547,800 | - | -6% |
| 06/03 | 48 | 49 | 47 | 48 | 0% | 2,046,200 | - | -5.88% |
| 06/02 | 48 | 49 | 48 | 48 | 0% | 1,116,200 | - | -5.88% |
| 06/01 | （IR情報）16:00 行使価額修正条項付新株予約権の月間行使状況に関するお知らせ |
| 06/01 | 49 | 49 | 48 | 48 | -2.04% | 491,500 | - | -5.88% |
| 05/29 | 49 | 50 | 48 | 49 | 0% | 1,182,400 | - | -3.92% |
| 05/29 | （空売り報告）Barclays Capital Securities Ltd 2,653,252株（0.66%）-0.04% |
| 05/28 | 50 | 50 | 48 | 49 | 0% | 2,229,300 | - | -5.77% |
| 05/28 | （空売り報告）MERRILL LYNCH INTERNATIONAL 1,868,840株（0.47%）-0.07%義務消失 |
| 05/27 | 49 | 50 | 49 | 49 | 0% | 633,400 | - | -5.77% |
| 05/26 | 49 | 50 | 49 | 49 | -2% | 337,700 | - | -5.77% |
| 05/25 | 50 | 51 | 49 | 50 | 0% | 826,400 | - | -5.66% |
| 05/22 | 49 | 51 | 48 | 50 | +2.04% | 1,595,200 | - | -5.66% |
| 05/22 | （空売り報告）Barclays Capital Securities Ltd 2,787,652株（0.7%）-0.12% |
| 05/21 | 49 | 50 | 48 | 49 | 0% | 1,971,300 | - | -7.55% |
| 05/21 | （空売り報告）MERRILL LYNCH INTERNATIONAL 2,160,340株（0.54%）+0.02% |
| 05/21 | （空売り報告）Barclays Capital Securities Ltd 3,284,452株（0.82%）-0.17% |
| 05/20 | 50 | 51 | 49 | 49 | -3.92% | 1,314,900 | - | -7.55% |
| 05/19 | 50 | 51 | 49 | 51 | +2% | 2,670,300 | - | -5.56% |
| 05/19 | （空売り報告）MERRILL LYNCH INTERNATIONAL 2,079,440株（0.52%）-0.01% |
| 05/19 | （空売り報告）Barclays Capital Securities Ltd 3,970,552株（0.99%）-0.39% |
| 05/18 | 50 | 51 | 48 | 50 | 0% | 4,248,800 | - | -7.41% |
| 05/18 | （空売り報告）MERRILL LYNCH INTERNATIONAL 2,130,440株（0.53%）-0.01% |
| 05/15 | 52 | 52 | 50 | 50 | -1.96% | 2,090,900 | - | -7.41% |
| 05/14 | （IR情報）16:00 HGF遺伝子治療用製品のType B CMC Meeting実施に関するお知らせ |
| 05/14 | 52 | 52 | 51 | 51 | -1.92% | 968,400 | - | -7.27% |
| 05/14 | （空売り報告）Barclays Capital Securities Ltd 5,482,752株（1.38%）-0.1% |
| 05/13 | 52 | 53 | 52 | 52 | 0% | 1,001,200 | - | -5.45% |
| 05/13 | （空売り報告）MERRILL LYNCH INTERNATIONAL 2,145,340株（0.54%）+0.01% |
| 05/12 | （空売り報告）MERRILL LYNCH INTERNATIONAL 2,136,940株（0.53%）+0.01% |
| 05/11 | （空売り報告）MERRILL LYNCH INTERNATIONAL 2,066,840株（0.52%）+0.01% |
| 05/08 | （IR情報）16:00 営業外収益、営業外費用及び法人税等調整額の計上に関するお知らせ |
| 05/08 | （IR情報）16:00 2026年12月期第1四半期決算短信〔日本基準〕(連結) |
10年以上蓄積したファイナンスデータとAIを掛け合わせて、投資の意思決定を加速させるポジションです。
